Talkspace (TALK) Competitors $2.56 -0.04 (-1.54%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$2.60 +0.04 (+1.76%) As of 09/12/2025 06:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TALK vs. AVAH, PACS, NAKA, VRDN, OMDA, TDOC, GRAL, AHCO, FTRE, and PNTGShould you be buying Talkspace stock or one of its competitors? The main competitors of Talkspace include Aveanna Healthcare (AVAH), PACS Group (PACS), KindlyMD (NAKA), Viridian Therapeutics (VRDN), Omada Health (OMDA), Teladoc Health (TDOC), GRAIL (GRAL), AdaptHealth (AHCO), Fortrea (FTRE), and The Pennant Group (PNTG). These companies are all part of the "healthcare" industry. Talkspace vs. Its Competitors Aveanna Healthcare PACS Group KindlyMD Viridian Therapeutics Omada Health Teladoc Health GRAIL AdaptHealth Fortrea The Pennant Group Talkspace (NASDAQ:TALK) and Aveanna Healthcare (NASDAQ:AVAH) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, analyst recommendations, dividends, risk, valuation, earnings and institutional ownership. Do analysts rate TALK or AVAH? Talkspace currently has a consensus price target of $4.50, suggesting a potential upside of 75.78%. Aveanna Healthcare has a consensus price target of $7.50, suggesting a potential downside of 11.14%. Given Talkspace's stronger consensus rating and higher possible upside, equities analysts clearly believe Talkspace is more favorable than Aveanna Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Talkspace 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 2 Strong Buy rating(s) 3.00Aveanna Healthcare 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60 Which has preferable valuation and earnings, TALK or AVAH? Talkspace has higher earnings, but lower revenue than Aveanna Healthcare. Aveanna Healthcare is trading at a lower price-to-earnings ratio than Talkspace, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTalkspace$202.61M2.12$1.15M$0.02128.00Aveanna Healthcare$2.02B0.87-$10.93M$0.08105.50 Do institutionals and insiders have more ownership in TALK or AVAH? 57.4% of Talkspace shares are held by institutional investors. Comparatively, 88.0% of Aveanna Healthcare shares are held by institutional investors. 23.5% of Talkspace shares are held by insiders. Comparatively, 7.8% of Aveanna Healthcare shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the media prefer TALK or AVAH? In the previous week, Aveanna Healthcare had 2 more articles in the media than Talkspace. MarketBeat recorded 5 mentions for Aveanna Healthcare and 3 mentions for Talkspace. Talkspace's average media sentiment score of 1.37 beat Aveanna Healthcare's score of 0.89 indicating that Talkspace is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Talkspace 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Aveanna Healthcare 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is TALK or AVAH more profitable? Talkspace has a net margin of 1.41% compared to Aveanna Healthcare's net margin of 0.85%. Talkspace's return on equity of 2.48% beat Aveanna Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Talkspace1.41% 2.48% 2.11% Aveanna Healthcare 0.85%-54.56%3.17% Which has more risk and volatility, TALK or AVAH? Talkspace has a beta of 1.09, meaning that its stock price is 9% more volatile than the S&P 500. Comparatively, Aveanna Healthcare has a beta of 2.04, meaning that its stock price is 104% more volatile than the S&P 500. SummaryTalkspace beats Aveanna Healthcare on 10 of the 16 factors compared between the two stocks. Get Talkspace News Delivered to You Automatically Sign up to receive the latest news and ratings for TALK and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TALK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TALK vs. The Competition Export to ExcelMetricTalkspaceMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$435.41M$2.15B$5.85B$10.14BDividend YieldN/AN/A5.68%4.60%P/E Ratio128.0635.7175.3425.98Price / Sales2.129.96514.55181.19Price / Cash218.8358.3137.5660.44Price / Book3.7111.6512.156.29Net Income$1.15M-$63.67M$3.29B$271.07M7 Day Performance-1.92%-0.25%0.74%3.87%1 Month Performance-0.78%2.21%4.82%4.88%1 Year Performance30.61%35.29%60.58%26.12% Talkspace Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TALKTalkspace4.0981 of 5 stars$2.56-1.5%$4.50+75.8%+39.1%$435.41M$202.61M128.06500Positive NewsAVAHAveanna Healthcare1.4994 of 5 stars$8.26+0.5%$7.50-9.2%+61.4%$1.72B$2.02B103.2533,500Short Interest ↑PACSPACS Group3.0645 of 5 stars$11.29+1.0%$33.33+195.4%-75.5%$1.70B$3.11B0.0032,433Trending NewsNAKAKindlyMD2.4533 of 5 stars$4.56+11.8%$8.00+75.4%N/A$1.53B$2.72M-5.30N/ANews CoverageOptions VolumeGap DownHigh Trading VolumeVRDNViridian Therapeutics2.2503 of 5 stars$19.81+5.8%$37.78+90.7%-8.8%$1.53B$300K-5.1750Positive NewsOMDAOmada HealthN/A$24.03-1.0%$24.50+2.0%N/A$1.40BN/A0.00849TDOCTeladoc Health2.8514 of 5 stars$7.84+0.2%$9.80+25.0%+1.0%$1.38B$2.57B-6.585,500Positive NewsGRALGRAIL0.6443 of 5 stars$38.23+3.6%$31.50-17.6%+180.7%$1.33B$125.60M-2.921,360Positive NewsAHCOAdaptHealth3.6894 of 5 stars$9.42-0.9%$13.40+42.3%-13.9%$1.29B$3.26B17.4410,500Positive NewsFTREFortrea3.1679 of 5 stars$10.32-11.3%$12.78+23.8%-51.0%$1.06B$2.70B-0.9115,500News CoverageAnalyst ForecastPNTGThe Pennant Group4.3496 of 5 stars$24.51+0.9%$34.40+40.4%-23.2%$839.51M$695.24M31.427,000 Related Companies and Tools Related Companies Aveanna Healthcare Competitors PACS Group Competitors KindlyMD Competitors Viridian Therapeutics Competitors Omada Health Competitors Teladoc Health Competitors GRAIL Competitors AdaptHealth Competitors Fortrea Competitors The Pennant Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TALK) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Talkspace, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Talkspace With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
